Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy and a Simple Model to Predict Response of BNT162b2 mRNA

NCT04862806 is registered in ClinicalTrials.gov with Bnai Zion Medical Center as lead sponsor.

NCT NCT04862806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04862806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy and a Simple Model to Predict Response of BNT162b2 mRNA
Lead sponsor
Bnai Zion Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2021
Completion date
March 31, 2022
Enrollment
1,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia